Standard BioTools Inc. (NASDAQ:LABORATORY) Third Quarter 2024 Earnings Conference Call, October 30, 2024, 4:30 p.m. ET

Participating company

David Holmes – IR
Michael Egholm – President and CEO
Alex Kim – Acting Chief Operating Officer and Chief Financial Officer

Conference call participants

Matt Stanton – Jefferies

Operator

Hello and welcome to the Standard BioTools Inc. Third Quarter 2024 Financial Results Conference Call. All participants will be in listen-only mode. After today’s presentation, there will be an opportunity to ask questions. (Operator Instructions) Please note that this event is being recorded.

I would now like to turn the conference over to David Holmes from Investor Relations. Please go ahead.

David Holmes

Thank you, operator, and good afternoon everyone. Welcome to Standard BioTools’ Third Quarter 2024 Earnings Conference Call. Leading the call today are Michael Egholm, President and CEO, and Alex Kim, Interim COO and CFO.

At market close today, Standard BioTools released its financial results for the quarter ended September 30, 2024. During the call, we will review our results and provide an update on our financial and operational performance, our outlook for 2024, market trends and our strategic initiatives. .

During the call, we will make forward-looking statements about events and circumstances that have not yet occurred, including plans and projections for our business, our outlook for 2024 and our future financial results, trends and opportunities of the market and our expectations linked to all activities. operations with SomaLogic, including potential synergies and our business prospects for the combined company.

These statements are subject to important risks and uncertainties that may cause actual events or results to differ materially from current circumstances. The forward-looking statements in this call are based on information currently available to us and we undertake no obligation to update these statements, except as required by law.

During the